Researchers at the University of Massachusetts Amherst have designed non-toxic Salmonella bacteria to deliver viruses that ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...

A new Yale study reveals that major organ systems in the body aren't just passive structures operating on directions from ...

A vitamin D-based therapy may help remodel the protective barrier surrounding pancreatic tumors, offering a potential new ...

Scientists have uncovered a surprising navigation system in pigeons: iron-filled immune cells in the liver that may act like ...

Researchers are investigating whether these medications, known as GLP-1 agonists or GLP-1 drugs, could treat everything from ...

Using Ozempic for weight loss without diabetes carries serious medical risks. Learn what experts say about its real impact on ...

A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of ...

For decades, giant mitochondria-known as megamitochondria-have been recognized in liver biopsies from patients with alcohol-associated liver disease (ALD).

Growing momentum for RAS inhibition at ASCO highlights Namodenoson’s RAS pathway inhibition and encouraging data in ...

Unprecedented results against a stubbornly hard-to-treat cancer are boosting optimism that other challenging tumors will be ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly untouchable tumour targets. The experimental drug, daraxonrasib, disarms all ...